Richard B Kim

Citado por

	Total	Desde 2019
Citas	41165	9871
Índice h	100	48
Índice i10	250	184

2300

1150

575

1725

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024182 245 367 633 1017 1377 1499 1851 1736 1953 1667 1896 2138 2259 2269 2122 1885 1975 1859 1791 1787 1681 1913 1739 1560 1168

Acceso público

Ver todo

91 artículos

31 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Ute I. SchwarzDirección de correo verificada de lhsc.on.ca
C. Michael SteinVanderbilt UniversityDirección de correo verificada de vumc.org
Dan RodenProfessor of Medicine, Pharmacology, and Biomedical Informatics, Vanderbilt University Medical CtrDirección de correo verificada de vanderbilt.edu
Erin SchuetzSt Jude Children's Research HospitalDirección de correo verificada de stjude.org
Wooin LeeSeoul National UniversityDirección de correo verificada de snu.ac.kr
Martin F. FrommChair, Professor of Clinical Pharmacology and Clinical Toxicology, Friedrich-Alexander-UniversityDirección de correo verificada de fau.de
Yun-Hee ChoiEpidemiology and Biostatistics, The University of Western OntarioDirección de correo verificada de schulich.uwo.ca
Marianne DeGorterSenior Scientist, Stanford UniversityDirección de correo verificada de stanford.edu
John D SchuetzSt. JudeDirección de correo verificada de stjude.org
Rob HegeleWestern University, Robarts Research InstituteDirección de correo verificada de robarts.ca
Stephen StromKarolinska Institutet, Previously University of PittsburghDirección de correo verificada de ki.se
Alfred L. George, Jr.Professor and Chair of Pharmacology, Northwestern UniversityDirección de correo verificada de northwestern.edu
Marylyn D RitchieUniversity of PennsylvaniaDirección de correo verificada de upenn.edu
Joseph A. WareSenior Vice President, Clinical PharmacologyDirección de correo verificada de a2-ai.com
Michael J KnauerUniversity of Western OntarioDirección de correo verificada de lhsc.on.ca
G Y ZouWestern UniversityDirección de correo verificada de robartsinc.com
David JuurlinkClinical Pharmacology and Toxicology, University of TorontoDirección de correo verificada de ices.on.ca
Kathleen M. GiacominiProfessor, UCSFDirección de correo verificada de ucsf.edu
Fred GuengerichProfessor of Biochemistry, Vanderbilt UniversityDirección de correo verificada de vanderbilt.edu
Sook Wah YeePfizerDirección de correo verificada de pfizer.com

Seguir

Richard B Kim

Western University

Dirección de correo verificada de lhsc.on.ca

Personalized Medicine Clinical Pharmacology Pharmacogenetics Drug Transporters Drug Metabolism


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Membrane transporters in drug development Nature reviews Drug discovery 9 (3), 215-236, 2010	3591	2010
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. RB Kim, MF Fromm, C Wandel, B Leake, AJ Wood, DM Roden, ... The Journal of clinical investigation 101 (2), 289-294, 1998	1326	1998
Identification of functionally variant MDR1 alleles among European Americans and African Americans RB Kim, BF Leake, EF Choo, GK Dresser, SV Kubba, UI Schwarz, ... Clinical Pharmacology & Therapeutics 70 (2), 189-199, 2001	1304	2001
Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance C Marzolini, E Paus, T Buclin, RB Kim Clinical Pharmacology & Therapeutics 75 (1), 13-33, 2004	1263	2004
SLC transporters as therapeutic targets: emerging opportunities L Lin, SW Yee, RB Kim, KM Giacomini Nature reviews Drug discovery 14 (8), 543-560, 2015	846	2015
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study DW Haas, HJ Ribaudo, RB Kim, C Tierney, GR Wilkinson, RM Gulick, ... Aids 18 (18), 2391-2400, 2004	799	2004
Genetic determinants of response to warfarin during initial anticoagulation UI Schwarz, MD Ritchie, Y Bradford, C Li, SM Dudek, A Frye-Anderson, ... New England Journal of Medicine 358 (10), 999-1008, 2008	772	2008
Molecular basis of ethnic differences in drug disposition and response HG Xie, RB Kim, AJJ Wood, CM Stein Annual review of pharmacology and toxicology 41 (1), 815-850, 2001	770	2001
Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European-and African-Americans RG Tirona, BF Leake, G Merino, RB Kim Journal of Biological Chemistry 276 (38), 35669-35675, 2001	761	2001
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine M Cvetkovic, B Leake, MF Fromm, GR Wilkinson, RB Kim Drug metabolism and disposition 27 (8), 866-871, 1999	755	1999
Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine GK Dresser, DG Bailey, BF Leake, UI Schwarz, PA Dawson, DJ Freeman, ... Clinical pharmacology & therapeutics 71 (1), 11-20, 2002	748	2002
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics RH Ho, RG Tirona, BF Leake, H Glaeser, W Lee, CJ Lemke, Y Wang, ... Gastroenterology 130 (6), 1793-1806, 2006	684	2006
Transporters and drug therapy: implications for drug disposition and disease RH Ho, RB Kim Clinical Pharmacology & Therapeutics 78 (3), 260-277, 2005	567	2005
The orphan nuclear receptor HNF4α determines PXR-and CAR-mediated xenobiotic induction of CYP3A4 RG Tirona, W Lee, BF Leake, LB Lan, CB Cline, V Lamba, F Parviz, ... Nature medicine 9 (2), 220-224, 2003	554	2003
Drugs as P-glycoprotein substrates, inhibitors, and inducers RB Kim Drug metabolism reviews 34 (1-2), 47-54, 2002	534	2002
Inhibition of P-glycoprotein–mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine MF Fromm, RB Kim, CM Stein, GR Wilkinson, DM Roden Circulation 99 (4), 552-557, 1999	530	1999
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes EF Choo, B Leake, C Wandel, H Imamura, AJJ Wood, GR Wilkinson, ... Drug Metabolism and Disposition 28 (6), 655-660, 2000	502	2000
Intestinal drug transporter expression and the impact of grapefruit juice in humans H Glaeser, DG Bailey, GK Dresser, JC Gregor, UI Schwarz, JS McGrath, ... Clinical Pharmacology & Therapeutics 81 (3), 362-370, 2007	485	2007
The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization V Dishy, GG Sofowora, HG Xie, RB Kim, DW Byrne, CM Stein, AJJ Wood New England Journal of Medicine 345 (14), 1030-1035, 2001	470	2001
Nuclear receptors and the regulation of drug‐metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs BL Urquhart, RG Tirona, RB Kim The Journal of Clinical Pharmacology 47 (5), 566-578, 2007	461	2007

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores